Related Experiment Video
Updated: Aug 11, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Rational design and applications of a Rac GTPase-specific small molecule inhibitor
Huzoor Akbar1, Jose Cancelas, David A Williams
1Division of Experimental Hematology, Children's Hospital Research Foundation, Cincinnati, OH, USA.
Abstract:
Rac GTPases are involved in the regulation of multiple cell functions and have been implicated in the pathology of certain human diseases. Dominant negative mutants of Rac have been the tool of choice in studying Rac function in cells. Given the difficulty of introducing high concentrations of the Rac mutants into primary cells and nonspecific effects of the mutants on Rho guanine nucleotide exchange factor (GEF) activities, it is desirable to develop small molecule inhibitors that could specifically inhibit Rac activities. Here we describe the rational design, characterization, and applications of a first-generation Rac-specific small molecule inhibitor. On the basis of the structure-function information of Rac interaction with GEFs, in a computer-based virtual screening we have identified NSC23766, a highly soluble and membrane permeable compound, as a specific inhibitor of a subset of GEF binding to Rac and, therefore, Rac activation by these GEFs. In fibroblast cells, NSC23766 inhibited Rac1 GTP-loading without affecting Cdc42 or RhoA activity and suppressed cell proliferation induced by a Rac GEF Tiam1. It has little effect on cell growth induced by a constitutively active Rac1 mutant. In addition, NSC23766 inhibited: (1) the anchorage-independent growth and invasion phenotypes of human prostate cancer PC-3 cells; (2) Rac activation and Rac-dependent aggregation of platelets stimulated by thrombin; and (3) Rac1 and Rac2 activities of hematopoietic stem/progenitor cells and induced their mobilization from mouse bone marrow to peripheral blood. Thus, NSC23766 is a lead small molecule inhibitor of Rac activity and could be useful for studying Rac-mediated cellular functions and for modulating pathological conditions in which Rac-deregulation may play a role.
Insights
Researchers developed NSC23766, a novel small molecule inhibitor that specifically targets Rac GTPase activity. This compound effectively inhibits Rac-mediated cellular functions and shows potential for treating diseases linked to Rac deregulation.
Area of Science:
- Molecular Biology
- Cell Signaling
- Drug Discovery
Background:
- Rac GTPases regulate crucial cell functions and are implicated in human diseases.
- Existing tools like dominant negative Rac mutants have limitations in primary cells and specificity.
- There is a need for specific small molecule inhibitors to study Rac function and target related pathologies.
Purpose of the Study:
- To rationally design, characterize, and apply a novel, first-generation Rac-specific small molecule inhibitor.
- To identify a compound that specifically inhibits Rac activation by targeting Rho guanine nucleotide exchange factor (GEF) interactions.
Main Methods:
- Computer-based virtual screening using structure-function information of Rac-GEF interactions.
- Characterization of the identified compound (NSC23766) in fibroblast cells, prostate cancer cells, platelets, and hematopoietic stem cells.
- Assays included measuring GTP-loading, cell proliferation, anchorage-independent growth, invasion, platelet aggregation, and stem cell mobilization.
Main Results:
- NSC23766 specifically inhibited Rac1 GTP-loading in fibroblasts without affecting Cdc42 or RhoA, suppressing Tiam1-induced proliferation.
- The inhibitor blocked anchorage-independent growth and invasion in PC-3 prostate cancer cells and Rac-dependent platelet aggregation.
- NSC23766 inhibited Rac1/2 in hematopoietic stem cells, promoting their mobilization from bone marrow.
Conclusions:
- NSC23766 is a potent and specific small molecule inhibitor of Rac activity, representing a lead compound.
- This inhibitor is valuable for elucidating Rac-mediated cellular processes.
- NSC23766 holds therapeutic potential for conditions involving Rac-deregulation.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins, also known...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
Activation and Inactivation of G Proteins
Cell Polarization by Rho Proteins

